ME Charities and APPG on ME write to Supermarkets & UK Government.

ME Research UK - letter explaining how things are for people with ME/CFS.

Letter sent to major supermarket chains and UK Government from UK ME charities and the All Party Parliamentary Group on ME
Posted on 27 Mar 2020

We are writing on behalf of the adults, children and young people we support who have Myalgic Encephalomyelitis (M.E.) (also known as Chronic Fatigue Syndrome, or CFS), asking for your help.

The Government has identified that people with chronic neurological conditions, including M.E./CFS, are at increased risk of severe illness from Coronavirus.

More than one in four people with M.E./CFS are so severely affected that they are unable to leave their homes independently, and even those with the milder form of this non-visible illness struggle to access services and support.

Many of those we support have relied on the excellent home delivery service you offer for years, to get food and essential supplies. But over the past few weeks the increased demand has meant they are unable to compete with healthy people who are able to spend longer online, searching for slots and sourcing deliveries.

We are also hearing from those who are able to visit stores who have tried to use the dedicated shopping times for those at risk – but who have been challenged because the debilitating pain, fatigue and cognitive difficulties that come with this non-visible condition cannot be seen.

We are now seeing a huge increase in the number of calls to our already busy helplines, with many telling us they do not have any food in the house.
While those who are house/bed-bound are not necessarily included in the Government’s official category of “vulnerable,” this does not give the full picture.

This group of increasingly desperate people are unable to visit a store and many have no friends or family to support them. They need urgent help now – please will you:

• include those house/bed-bound by M.E./CFS in your priority access group for your online service?
• allow those with M.E./CFS, who are able to leave the house, access to priority shopping times in store?

We would be happy to provide our members with a resource they can download that shows they have a chronic neurological condition and are eligible to use this service.

Our teams are happy to help answer any questions or provide more information.

Carol Monaghan MP, Chair, APPG for M.E.

The Countess of Mar, Chair of Forward-ME

Ben Lake MP; Jim Shannon MP ; Mark Tami MP Dr James Davies MP; Edward Davey MP: Alex Sobel MP; Dame Diana Johnson MP.

Sonya Chowdhury, Chief Executive Action for M.E.

Nigel Riley, Chair, ME Association

Sue Waddle, Vice Chair, ME Research UK

Esperanza Moreno, #MEAction UK

Helen Winning, Chief Executive, The ME Trust

Simon Lawrence, Chair, The 25% ME Group

Jane Colby, Executive Director, Tymes Trust

Janice Kent, Director, reMEmber

Dr Nina Muirhead, Chair, Medical Education Group UK CFS/ME Research Collaborative

Dr William Weir

Dr Nigel Speight
 

A very large genetic study into ME/CFS.
The ME/CFS Biomedical Partnership are asking for help.  Sign up on the website, to indicate if you want to hear about the study, and whether you want to take part.  The FAQs page answers many questions, under several topics - Science/Research; Recruitment/Taking Part; Funding; The Partnership; and Public & Patient Involvement.
ME/CFS Biomedical Partnership: Genetics and Biomarkers is a partnership of researchers, people with ME/CFS, carers and the public.

Early in 2020, the partnership will make a grant application to the Medical Research Council and the National Institute for Health Research for a very large genetic study into ME/CFS known as a genome-wide association study.
The project will be led by Prof Chris Ponting at the University of Edinburgh in partnership with the UK ME/CFS Biobank at the London School of Hygiene & Tropical Medicine.

The study will analyse DNA from the saliva of 20,000 ME/CFS patients to see whether ME/CFS is partly genetic and if so, what causes it. The study should help us understand the disease and find treatments.

The ME/CFS Biomedical Partnership Patient and Public Involvement (PPI) Steering Group is made up of people representing groups or networks from the ME/CFS community, including Sonya Chowdhury of Action for ME (AfME), Dr Charles Shepherd of the ME Association (MEA), and the Countess of Mar of Forward-ME.

Find out more -
AfME and the MEA both recently gave further explanations, and the MEA January monthly survey asks -  would you be willing to take part in research that will investigate the genetics of M.E.?

Two recent useful explanatory blogs, both with comments and responses -
• Trial By Error: The UK’s Proposed Genetics Study, By David Tuller, DrPH.
• Sign up! Your support could help win funding for a game-changing ME/CFS study, By Simon McGrath.

Further background information can be found from the AfME article “ME/CFS Biomedical Partnership”, plus the Forward-ME six page leaflet “The ME/CFS Biomedical Partnership: Genetics and Biomarkers Genome-wide association study: Questions & Answers”, and the MEA article “ME/CFS Biomedical Partnership PPI Steering Group Update”.

Four recent publications -
 "Supporting you and your patients with ME/CFS" - Forward-ME's Briefing for GPs.
"A Community … and ME" - Invest in ME Research’s new 42 page booklet.
"Worcestershire GPs’ CFS/ME referral protocol" - highlighted on our blog, in April this year.
"ME Association Clinical and Research Guide" - The Purple Book, 2019 edition.

The following gives more information about these publications  -

• Help your GP understand M.E. -
"Supporting you and your patients with ME/CFS" - Forward-ME's Briefing for GPs.
Copies of the 4 page Forward-ME Briefing "Supporting you and your patients with ME/CFS" were distributed at the Royal College of GPs Conference in Liverpool last month.  During the conference, Action for ME and the ME Association advised GPs on how they can best help people with M.E./CFS.

• Help everyone understand M.E.-
"A Community … and ME" - Invest in ME's 42 page booklet. 
In order to raise awareness of how ME affects a community, Invest in ME Research looks at some figures in society and views their perception of the disease and the problems they are confronted with.   The new downloadable booklet, available to share.

• Help your Worcestershire GP understand M.E.. -
"Worcestershire GPs’ CFS/ME referral protocol" - highlighted on the Worcestershire ME Social Group’s blog in April this year.  Also highlighted on the Group’s handout.

• Help your healthcare professional understand M.E. -
"ME Association Clinical and Research Guide".  Free copies of The Purple Book - 2019 edition are available for health professionals.  The MEA again offer free copies of the 214 page print version to GPs, NHS consultants and other healthcare professionals in the UK.   Highlighted on the Group’s handout.

• Help your Parliamentary Candidates understand M.E. -
If you see your local candidates or their representatives, tell them about this blog, the Worcestershire ME Social Group’s website, and our social gatherings.  Worcestershire MPs' contact information will be updated on the Social Group’s website after the General Election.

M.E. Parliamentary Debate, in the House of Commons, Thursday, 24 January, 2.00pm. (Motion quoted further below.)

All Worcestershire MPs are encouraged to attend this important debate secured by Carol Monaghan MP.  Write to your MP. 

Robin Walker, MP for Worcester, said “I believe that research into this area is vital”, in a letter following the M.E. debate held in June 2018.

On 24 January, biomedical research will be amongst a number of major issues and concerns raised. 

These are referred to in the motion:
“That this House calls on the Government to provide increased funding for biomedical research into the diagnosis and treatment of M.E., supports the suspension of Graded Exercise Therapy and Cognitive Behaviour Therapy as means of treatment, supports updated training of GPs and medical professionals to ensure they are equipped with clear guidance on diagnosis of M.E. and appropriate management advice to reflect international consensus on best practice, and is concerned about the current trends of subjecting M.E. families to unjustified child protection procedures.”

These issues and concerns are described in more detail in the briefing document that has been prepared and supported by national charities, who are members of the Forward ME group of charities.

The ME Association, and Action for ME give full information on this week’s debate. 

The June 2018 debate is available to watch on Youtube, and you can read the full Hansard transcript.

Have you received or been offered Cognitive Behavioural Therapy (CBT) and/or Graded Exercise Therapy (GET) in the UK since 2007?

The Forward ME group of charities has launched a survey, having been asked by the National Institute of Health and Care Excellence (NICE) to gather evidence and experiences.

ME Research UK (MERUK) CEO, Simon Phillips, welcomed the launch of the survey, adding:
As one of the funders of the CBT and GET Patient Survey and as an active member of the Forward-ME Group, ME Research UK encourages all those who have undertaken or were offered CBT or GET in the UK since 2007 to take this opportunity to contribute before the end of January 2019. This will allow Forward-ME to submit the results to NICE for them to use as part of their review of the current Guideline. We will await the results of Oxford Brookes University’s analysis of the results with keen interest.

The ME Association (MEA) explain the deadline:
The deadline for completing the questionnaire is the 31st January 2019, to meet the very narrow time frame set out by NICE. 
Unfortunately, this also means that Forward ME do not have the time or capacity to send out/accept paper copies. We will make it very clear to NICE when we submit the report that those unable to complete the survey online, including many severely affected people, have not been able to take part.
The survey is however designed to allow a carer, parent or another person to fill it in on behalf of someone else if they are unable to do this themselves.

Join in discussions on social media groups.

Information from the Worcestershire NHS CFS/ME Local Multi-Disciplinary Team (LMDT): Nice guidelines (2007) suggest that the most effective treatments are Cognitive Behavioural Therapy (CBT) to help improve the way you feel about the condition, and Graded Exercise Therapy (GET) to gradually build up exercise tolerance and improve fatigue levels. The principles of these therapies underpin the treatment provided by the Worcestershire CFS/ME Service.

Please sign and forward petition:  “Stop harming ME/CFS patients - take CBT/GET out of NICE guidelines NOW”. 
Expected Publication date by NICE: 14 October 2020.
NICE has promised to review its current guidelines on ME/CFS, which is not scheduled to be completed until October 2020.  Meanwhile it has left the current guidelines in place, despite the recommendations for treatments that are known to be harmful.  

ME/CFS NICE Guideline updates from ME Association (MEA), Action for ME (AfME), Forward ME, and ME Research UK (MERUK).

MEA:  NICE ME/CFS Guideline Review: Publication of revised Scope, comments, and committee appointments | 16 October 2018.

AfME:  NICE publishes final scope for M.E./CFS guideline.
October 16, 2018.  The National Institute for Health and Care Excellence (NICE) has published its final scope for its updated guideline on M.E./CFS, along with consultation comments and committee appointments.

MEA:  Forward ME – Stakeholder deliberations over NICE Scope for ME/CFS | 22 October 2018.

AfME:  NICE guideline scope and committee: update & comment.
October 25, 2018.  
 
MERUK:  NICE ME/CFS Guideline Committee - ME Research UK’s Comment.
Posted on 29 Oct 2018.
ME Research UK joined other charities and those affected by ME/CFS in welcoming the long-awaited review of the NICE Guideline on ME/CFS.  Given the concerns expressed by many about the scope and content of the current Guideline, this review is vitally important and ME Research UK, as a stakeholder, has submitted its views to NICE during its consultation period.
We agree that it is important to listen and understand the views of a range of experts in order to ensure that the revised Guideline provides clarity for everyone who is affected by it - patients and clinicians - but the Guideline must be based on the best available research and the replacement Guideline written with objectivity.
ME Research UK wishes to express its disappointment with the current appointment of a comparatively small number of members of the ME/CFS Guideline Committee who have expertise on the biomedical basis of ME/CFS when compared to those whose background appears to favour the bio psychosocial model. Given the increasing evidence of a biomedical origin of the illness and the current uncertainty, for example, of the soundness of the PACE trial, this is to be regretted. 
We look forward to following the progress of the committee with interest and we hope that the views of those with biomedical expertise are heard and that the revised Guidelines will improve the situation for the many, many thousands of people affected by this illness.

ME Association Statement re: NICE ME/CFS Guideline Review and Committee Appointments | 09 November 2018. 
by Dr Charles Shepherd, Hon. Medical Adviser, ME Association.
The ME Association has always been very clear on the position we take on the current (2007) NICE clinical guideline.
We believe that many of the key recommendations are unfit for purpose - especially those regarding the use of CBT and GET for everyone with mild or moderate ME/CFS.
We have played a key role in persuading NICE that a new guideline is required. The new guideline must recognise that ME/CFS is a serious multisystem disease and not a psychological illness.

NICE news article - NICE announces next steps in updating its guideline on ME/CFS.

A workshop last month with stakeholders marked the formal start of NICE’s collaborative work to update its 2010 guideline on the diagnosis and management of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
 
NICE Guideline - ME/CFS : Diagnosis and Management
A New Guideline is in development, with expected publication date: 14 October 2020.  This Guideline will fully update (CG53)

 
Forward-ME members discussed the NICE Guideline when they met on 10 January, a week before the NICE Guideline Stakeholder Engagement workshop.   Forward-ME is a collaboration of ME/CFS charities - chaired by the Countess of Mar.

 
Reports following the workshop:

• Dr Charles Shepherd, the ME Association’s Medical Adviser summarised the key points;  and the MEA announced the NICE News item - 
• Sue Waddle, Vice Chair of ME Research UK (MERUK) attended the workshop and gave her comments in the MERUK NICE Guideline Report
• Action for M.E.’s report on their involvement at the NICE guideline meeting, and further report -

 
 
Information from the Worcestershire NHS CFS/ME Service website:
Worcestershire Health & Care NHS Trust Extract from ‘Family & Friends Area’ -
Treatments for CFS/ME
Nice guidelines (2007) suggest that the most effective treatments are Cognitive Behavioural Therapy (CBT) to help improve the way you feel about the condition, and Graded Exercise Therapy (GET) to gradually build up exercise tolerance and improve fatigue levels. The principles of these therapies underpin the treatment provided by the Worcestershire CFS/ME Service.

 January 2015

Dr Alastair Miller (Medical Adviser to AFME [Action for ME], and Chair of BACME [British Association for CFS/ME])

For your interest, Dr Alastair Miller was the guest speaker at the January Forward-ME meeting. 

Dr Miller was the lead Clinician for the Herefordshire & Worcestershire CFS/ME Service, until he moved to Liverpool in 2005.  His position was - Consultant Physician in Infectious Disease and General Internal Medicine–Worcestershire Acute Hospitals NHS Trust.

www.forward-me.org.uk/20th%20Jan%202015.htm

www.meresearch.org.uk/news/forward-me-group-minutes-4/

 

The MEA’s Forward-ME article (below), includes two questions they submitted in advance of the meeting.

Minutes of meeting of Forward ME Group | main speaker, Dr Alastair Miller | 20 January 2015 www.meassociation.org.uk/2015/02/minutes-of-meeting-of-forward-me-group-main-speaker-dr-alastair-miller-20-january-2015/

MINUTES OF A MEETING OF THE FORWARD ME GROUP HELD IN THE HOUSE OF LORDS ON 20 JANUARY 2015

This meeting included a presentation from Dr Alastair Miller, representing the British ME Association for CFS/ME (/www.bacme.info/default.aspx)  Topics covered during a Question and Answer session included the NICE guideline, PACE trial, CBT and GET and the provision of supporting medical evidence for DWP benefit purposes

Questions submitted in advance by the ME Association:

QUESTION 1

Professor Mark Baker told the group at our meeting in June 2014 that the 2007 NICE Guideline on ME/CFS was no longer meeting the needs of people with ME/CFS and should be replaced. However, any instruction to do so must now come from NHS England. Does BACME share our view that the guideline cannot be allowed to sit in the NICE ‘static list’ and must be replaced by guidance that reflects the heterogeneity of ME/CFS in relation to both clinical presentation and pathology, and that management needs to personalised to reflect this heterogeneity.

QUESTION 2

Many people with ME/CFS continue to experience great difficulty in obtaining DWP benefits that they should be entitled to and only succeed on going to appeal. Providing supportive medical evidence from a range of health professionals is often a key to success but some health professionals working in NHS referral centres are reluctant, or even refuse, to become involved in DWP benefit applications. Does BACME issue any guidance on the provision of written reports that contain supportive medical evidence for patients who require this information?

MINUTES www.forward-me.org.uk/20th%20Jan%202015.htm

FORWARD-ME

Minutes of the Meeting held in the Television Interview Room, House of Lords

Tuesday 20 January 2015, 2pm

Present:

Countess of Mar (Chairman)
Janice Kent (reMEmber)
Christine Harrison (BRAME)
Dr Charles Shepherd (ME Association)
Sonya Chowdhury (AFME)
Dr Paul Worthley
Sue Waddle (ME Research UK)
Jane Colby (TYMES Trust)
Anita Williams (TYMES Trust)

1.Apologies were received from Bill Kent, Christine Harrison, Hannah Clifton and Mary-Jane Willows

2.Guest Speaker, Dr Alastair Miller, Medical Adviser to AFME and BACME

2.1 Dr Miller explained he was an infectious diseases physician. He had spent seven years in the Royal Navy, and since then he had practised in Worcestershire and latterly in Liverpool. He had taken a long-term interest in ME/CFS. He had found it affected all ranks in the RN, and he was well aware of the “payback” effect. In Worcestershire they had a county-wide ME/CFS service that extended into Herefordshire. In Liverpool about one-fifth of his work was to do with ME/CFS; their service involved consultants and various therapists. He became medical adviser to AFME about five years ago and was a founder member of BACME. He had probably seen altogether about 3,000 patients with ME/CFS – an average of 100 a year.

2.2 Dr Miller said he did not think that ME was a “diagnosis of exclusion”. You could make a very positive diagnosis from observing the patient’s condition and history – things like payback (post-exertional malaise), brain fog etc. It was a different fatigue from that experienced with cancer and other chronic conditions, and there was a massive difference between “chronic fatigue” and ME/CFS. Although a lot of research was taking place, there was no clear consensus on the mechanism of the illness – and there are other conditions where this applies –eg chronic tension headaches.

2.3 Turning to treatment Dr Miller said the PACE trial had given an evidence base to the treatments already being given in the ME/CFS centres (ie CBT and Graded Exercise). BACME was currently drafting a document on the control of symptoms. He was aware of controversy of the around the NICE Guideline but unfortunately there was not another treatment with an evidence base.

2.4 Dr Charles Shepherd referred to Forward-ME’s meeting with Professor Mark Baker of NICE. We had voiced our concerns and he didn’t want to dismiss any of them. He seemed to agree there should be a revision of the Guideline, but apparently that decision was no longer up to NICE but a matter for NHS England, and there is already a backlog of other guidelines to consider. So the ME/CFS Guideline was now on the “static list” and apparently nothing could be done unless NHS England could be persuaded to change its mind. He would be interested to know the views of Dr Miller and BACME on this.

2.5 Dr Miller said he accepted the Guideline had its limitations but there was not yet an evidence base for other therapies. What were members hoping for in a revised guideline? Dr Charles Shepherd suggested a less dogmatic, “one size fits all” approach. Sue Waddle said that the current guideline did not draw attention to the devastating effect Graded Exercise could have on patients. Vigorous exercise could result in relapse. Charles Shepherd said the problem was not just CBT and GET, there were other shortcomings and omissions in the Guideline. For example NICE did not mention immune dysfunction and the autonomic nervous system. Dr Miller said the guidance BACME would be putting out should help there. Professor Julia Newton had contributed on the autonomic nervous system and measures that can be taken to treat that.

2.6 There was further discussion between Dr Miller and members about the need for better guidance, including the considerable numbers of patients referred who were found to have conditions other than ME. Dr Miller pointed out that he had said in the AFME magazine that any patient referred as having ME had to be approached with an open mind. BACME had no direct contact with NHS England and he was not sure it would be helpful to revise the NICE Guideline at this stage. Data from the NOD study was showing that some patients were worse after CBT or GET, some remained the same and at least one third showed improvement.

2.7 Janice Kent expressed concern about GPs being not very good at diagnosis of ME/CFS. GPs in her locality wanted their ME patients to be seen by an expert doctor, but the bulk of patients referred to their local service did not get to see one. She was also concerned about the number of patients who were eventually shown to have other conditions (eg diabetes, vasculitis and lupus). Dr Miller commented that GP education was important, and access to good secondary care and accurate diagnosis were essential.

2.8 Jane Colby drew attention to the plight of children with the illness. Doctors were getting these children to go back to school in a way that was like graded exercise which they couldn’t manage. If these children could then not attend school, Social Services were brought in and there were threats of Care Orders. Doctors should be considering other forms of education for these children. She said that Dr Mark Van Ness had shown how patients become more unwell a day or two after exertion. There had been talk in the media of patients being afraid of exercise, but Dr W Weir had written that fear of feeling unwell as an inevitable result of exercise was perfectly rational. She could not see why the Van Ness findings (scientific evidence) could not be used in revised guidance. Other members said that NICE seemed to confirm the erroneous view that ME is a psychosomatic condition.

2.9 Dr Miller said there was nothing in the NICE Guideline to suggest ME was psychosomatic. Consultants like him were well aware that it was not. Until recently every patient referred to the Liverpool ME/CFS service had been seen by a consultant, but because of greatly increased workload they had reluctantly decided that patients with a positive diagnosis of ME/CFS from their GPs would go directly to therapy; the consultants would concentrate on those whose GPs were unsure about the diagnosis or where some other factor gave cause for concern. Figures given at a BACME conference had shown that 40 to 50% of referrals had gone directly to therapy (members pointed out that many of the services do not have a consultant). Regarding children, he said he was not a paediatrician, and at Liverpool they did not see anyone under the age of 18.

2.10 Members asked Dr Miller to clarify his statement about the proportion of patients that get worse after CBT or GET. Dr Miller said the correct position was that two thirds show some improvement and the other third show no change – or in some cases they get worse.

2.11 Sonya Chowdhury said that, regardless of what we think about NICE, the system was not working. What could we do to improve practice? At present some people were getting CBT or GET for whom it was not appropriate. We needed to counter the idea that all patients needed was vigorous exercise through exercise on prescription, for example. Dr Miller said that they had not been very happy with some patients not now seeing a consultant. BACME was very keen to have a clinician-led service but there were just not enough resources. However, at Liverpool every patient’s details were reviewed by a physician and each case was discussed with the therapists. They had picked up a Parkinson’s sufferer in this way. He believed all the centres were working in this way. Asked about Pacing he said he was not clear how it differed from GET but he recognised that some people needed a very gentle form of exercise, and he could advise them on drugs to control other symptoms.

2.12 Referring to patients for whom CBT and GET were not helpful, Dr Paul Worthley said there were alternative treatments which some patients found helpful but GPs were disinclined to recommend them. Dr Miller said he was open-minded to alternative treatments. If you take something that makes your symptoms better, that’s good but beware of anything that may be toxic or very expensive. The Chairman pointed out that the NICE Guideline says there may be alternative therapies that patients find helpful and they should discuss that with their GPs. Dr Miller agreed but said a number of patients in Liverpool had seen private practitioners at vast expense. Desperate people would grasp at anything.

2.13 Dr Charles Shepherd asked if there was any guidance on consultants providing “supporting evidence” (eg in a letter for benefits purposes) to patients who needed it. Dr Miller said there was not.

2.14 The Chairman thanked Dr Miller for his presentation and for answering so many questions.

3. Minutes of last meeting (2 December 2014) were agreed to be a true record.

4. Matters arising.

Leaflet on Mental Health Act (item 6 of last meeting). Sonya Chowdhury said Cathy Stillman-Low had been unwell but hoped to resume work on this soon. She would be grateful for any comments members might have. Sue Waddle said some questions in this area could be very difficult to deal with – for example a parent who was in danger of their child being taken into care and facing large legal bills but with no Legal Aid. What could we say? The Chairman said it was very difficult to get any lawyer to do pro bono work now. Sonya said there was no “pot of money” available to provide for that level of legal help. Cathy was aware of that. The leaflet would be aimed at giving people the basic information they need – a starting point. She would be in touch with national organisations that dealt with advocacy to see what might be put into the leaflet on that subject, so that people would know who the experts are that they could turn to. The Chairman referred to the TYMES leaflet on this subject which, she said, was very helpful

5. DWP

5.1 Dr Charles Shepherd said not much had happened since our last meeting. The main item of news was the transfer of contract from Atos to Maximus who had taken on Sue Marsh, the disability rights campaigner, as their “customer experience manager”. The Chairman said she would ask Sue Marsh to come and speak at our next meeting. Charles Shepherd added that many of the Atos staff were transferring to Maximus and would continue to use the same premises, and the same DWP guidance on eligibility criteria.

5.2 PIP. There was considerable discussion. Dr Charles Shepherd reported the MEA were getting more queries about PIP than about ESA. Christine Harrison asked members to send her their comments on PIP – what patients had told them etc – so she could take them to her meetings with DWP. She also advised people to ask for their DLA files because these would be destroyed after 18 months and they might be needed, if making an appeal, for example.

6. Research

6.1 Dr Paul Worthley asked for an update on the PACE trial controversy. Charles Shepherd said it had been heartening to see criticisms from professionals in journals such as the BMJ. Members discussed reporting in the media along the lines of “patients decline exercise” Dr Willy Weir had written a very good letter correcting these apparent misunderstandings and so had Dr Mark Van Ness. The Chairman offered to draft a letter to the Daily Telegraph; members to approve the draft. This was agreed. The editor of the Kumar and Clarke medical textbook had written to say that they were not prepared to change the entry for CFS/ME after consulting the authors. The Chairman would take advice from the MDU.

7. Any other business

7.1 Jane Colby reported that on Amazon you could buy a course of CBT for £39, and thereby become a certified CBT practitioner. She distributed a paper she had printed off. The certificate was apparently issued by some holistic treatment organisation.

7.2 “Words to avoid”. The Chairman suggested that we should use the words “post-exertional malaise” in preference to “fatigue”.

7.3 Dr Charles Shepherd reported the Royal Society of Medicine were organising a half-day seminar on ME on 18 March – for RSM members but there would be some seats for members of charities. He had written to Annette Brooke MP about a possible 5-minute slot on politics. If she could not be there would the Chairman be willing to speak? The Chairman agreed.

7.4 The Chairmen referred to a report by the US National Institute for Health which had described the Oxford criteria as inappropriate and indeed damaging. She would put this in her letter to the Daily Telegraph.

8. Date of next meeting Tuesday 24 February – Sue Marsh